{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-077497","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2025-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.918107+00:00","generated_at":"2026-05-17T12:29:03.698405+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Unicycive sells 3.55M shares for ~$16.3M net via ATM offering","bullets":["Sold 3,549,846 shares at average $4.56 per share since June 30, 2025.","Net proceeds after fees approximately $16.3 million.","Sales executed under November 2024 sales agreement with Guggenheim Securities.","Stock trades on Nasdaq Capital Market under ticker UNCY."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-077497","json":"https://secwatch.observer/filing/0001213900-25-077497.json","markdown":"https://secwatch.observer/filing/0001213900-25-077497.md","text":"https://secwatch.observer/filing/0001213900-25-077497.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025077497/0001213900-25-077497-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025077497/ea0253521-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:29:03.698405+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}